How to buy Aemetis stock | $19.96

Aemetis Inc is an oil & gas refining & marketing business based in the US. Aemetis shares (AMTX) are listed on the NASDAQ and all prices are listed in US Dollars. Aemetis employs 164 staff and has a trailing 12-month revenue of around 0.00.

Aemetis stock price (NASDAQ: AMTX)

Use our graph to track the performance of AMTX stocks over time.

Aemetis shares at a glance

• Key figures

Information last updated 2021-10-23.

Latest market close	$19.96
52-week range	$1.96 - $27.44
50-day moving average	$16.62
200-day moving average	$13.79
Wall St. target price	$30.83
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-2.21

Buy Aemetis shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Aemetis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aemetis price performance over time

Historical closes compared with the close of $19.96 from 2021-10-22

1 week (2021-10-15)	N/A
1 month (2021-09-24)	35.78%
3 months (2021-07-26)	101.41%
6 months (2021-04-26)	6.34%

1 year (2020-10-23)	396.52%
2 years (2019-10-25)	1,925.57%
3 years (2018-10-25)	2,168.18%
5 years (2016-10-25)	1,088.10%

Is Aemetis under- or over-valued?

Valuing Aemetis stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aemetis's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Aemetis's EBITDA

Aemetis's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $7.4 million.

The EBITDA is a measure of a Aemetis's overall financial performance and is widely used to measure a its profitability.

Aemetis financials

Revenue TTM	$175.9 million
Gross profit TTM	$11 million
Return on assets TTM	-10.7%
Return on equity TTM	0%
Profit margin	-31.53%
Book value	$-6.52
Market capitalisation	$632.5 million

TTM: trailing 12 months

Shorting Aemetis shares

There are currently 3.9 million Aemetis shares held short by investors – that's known as Aemetis's "short interest". This figure is 0.9% down from 4.0 million last month.

There are a few different ways that this level of interest in shorting Aemetis shares can be evaluated.

Aemetis's "short interest ratio" (SIR)

Aemetis's "short interest ratio" (SIR) is the quantity of Aemetis shares currently shorted divided by the average quantity of Aemetis shares traded daily (recently around 1.2 million). Aemetis's SIR currently stands at 3.35. In other words for every 100,000 Aemetis shares traded daily on the market, roughly 3350 shares are currently held short.

However Aemetis's short interest can also be evaluated against the total number of Aemetis shares, or, against the total number of tradable Aemetis shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aemetis's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Aemetis shares in existence, roughly 120 shares are currently held short) or 0.1374% of the tradable shares (for every 100,000 tradable Aemetis shares, roughly 137 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aemetis.

Find out more about how you can short Aemetis stock.

Aemetis share dividends

We're not expecting Aemetis to pay a dividend over the next 12 months.

Have Aemetis's shares ever split?

Aemetis's shares were split on a 4:1 basis on 14 June 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Aemetis shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Aemetis shares which in turn could have impacted Aemetis's share price.

Aemetis share price volatility

Over the last 12 months, Aemetis's shares have ranged in value from as little as $1.96 up to $27.44. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aemetis's is -0.4735. This would suggest that Aemetis's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aemetis has bucked the trend.

Aemetis overview

Aemetis, Inc. operates as a renewable natural gas and fuels, and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products. It owns and operates an ethanol facility in the California Central Valley near Modesto; and a renewable chemical and advanced fuel production facility on the East Coast of India. The company sells biodiesel and refined glycerin to transport companies, resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces and sells ethanol; and wet distiller's grains, distiller's corn oil, and condensed distillers solubles to dairies and feedlots as animal feed, as well as other health care and sanitary products, and industrial and potable alcohol for beverage spirits. In addition, it produces dairy biogas; and high-grade sanitizer alcohol and various feed products, as well as researches and develops efficient conversion technologies using waste feedstocks to produce biofuels and biochemicals.

Frequently asked questions

What percentage of Aemetis is owned by insiders or institutions?
Currently 6.746% of Aemetis shares are held by insiders and 62.802% by institutions. How many people work for Aemetis?
Latest data suggests 164 work at Aemetis. When does the fiscal year end for Aemetis?
Aemetis's fiscal year ends in December. Where is Aemetis based?
Aemetis's address is: 20400 Stevens Creek Boulevard, Cupertino, CA, United States, 95014 What is Aemetis's ISIN number?
Aemetis's international securities identification number is: US00770K2024 What is Aemetis's CUSIP number?
Aemetis's Committee on Uniform Securities Identification Procedures number is: 00101P102